Friday, 21 December 2018

Chugai broadens label for Hemlibra in Japan - The Pharma Letter

Chugai broadens label for Hemlibra in Japan  The Pharma Letter

Tokyo-based Chugai Pharmaceutical (TYO: 4519) has won Japanese approval for additional dosing options for Hemlibra (emicizumab), a coagulation factor VIII ...

Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)